Centene Management
Management criteria checks 1/4
Centene's CEO is Sarah London, appointed in Mar 2022, has a tenure of 2.08 years. total yearly compensation is $18.56M, comprised of 7.5% salary and 92.5% bonuses, including company stock and options. directly owns 0.018% of the company’s shares, worth $7.31M. The average tenure of the management team and the board of directors is 2.5 years and 2.4 years respectively.
Key information
Sarah London
Chief executive officer
US$18.6m
Total compensation
| CEO salary percentage | 7.5% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.5yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15
Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Is Now The Time To Put Centene (NYSE:CNC) On Your Watchlist?
Oct 26Centene Q3 2022 Earnings Preview
Oct 24Centene: Future Growth Will Exceed Market Expectations
Oct 14Centene: A Chaos Stock
Sep 28Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?
Sep 20Centene falls 7%, most since April 2021, on surging volume
Sep 14If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 28Centene Q2 2022 Earnings Preview
Jul 25Centene Keeps Overdelivering - But Is Expensive
Jul 11Is Centene (NYSE:CNC) Using Too Much Debt?
Jun 16Centene: Solid Q122 Earnings For Health Insurer Helps Make Buy/Hold Case
Apr 28Centene Has Overdelivered - It Is Time For A 'Hold'
Mar 24We Think Centene (NYSE:CNC) Can Stay On Top Of Its Debt
Mar 14Centene: Finally Gets Respect And Is Poised To Profit
Dec 31Is Centene (NYSE:CNC) A Risky Investment?
Dec 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$19m | US$1m | US$3b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$13m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$1b |
| Dec 31 2021 | US$15m | US$978k | US$1b |
Compensation vs Market: Sarah's total compensation ($USD18.56M) is above average for companies of similar size in the US market ($USD13.51M).
Compensation vs Earnings: Sarah's compensation has increased by more than 20% in the past year.
CEO
Sarah London (42 yo)
2.1yrs
Tenure
US$18,556,966
Compensation
Ms. Sarah M. London has been the Chief Executive Officer of Centene Corporation since March 21, 2022 and serves as its Director since September 2021. She served as President of Health Care Enterprises and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.1yrs | US$18.56m | 0.018% $ 7.3m | |
| President | 1.3yrs | US$10.62m | 0.010% $ 4.2m | |
| Executive VP & CFO | 2.9yrs | US$9.91m | 0.036% $ 14.6m | |
| Executive VP | 4.2yrs | US$4.84m | 0.017% $ 7.0m | |
| CEO of Markets & Medicaid | 5.3yrs | US$6.20m | 0.0089% $ 3.6m | |
| Chief Operating Officer | less than a year | no data | no data | |
| Senior VP | 3yrs | no data | 0.0053% $ 2.2m | |
| Chief Information Officer | 1.3yrs | no data | no data | |
| Senior Vice President of Investor Relations | 4yrs | no data | no data | |
| Chief Risk | 1.6yrs | no data | no data | |
| Senior VP & Chief Communications Officer | less than a year | no data | no data | |
| Senior VP & Chief Marketing Officer | 2.9yrs | no data | no data |
2.5yrs
Average Tenure
55.5yo
Average Age
Experienced Management: CNC's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.6yrs | US$18.56m | 0.018% $ 7.3m | |
| Independent Director | 1.4yrs | US$324.98k | 0.00026% $ 105.5k | |
| Independent Chairman | 18yrs | US$537.45k | 0.032% $ 13.0m | |
| Independent Director | 2.3yrs | US$369.98k | 0.0037% $ 1.5m | |
| Lead Independent Director | 4.3yrs | US$474.98k | 0.0042% $ 1.7m | |
| Independent Director | 2.3yrs | US$372.48k | 0.0014% $ 567.9k | |
| Independent Director | 2.3yrs | US$349.98k | 0.0047% $ 1.9m | |
| Director | 2.3yrs | US$1.25m | 0.083% $ 33.5m | |
| Independent Director | 6.2yrs | US$344.98k | 0.0035% $ 1.4m | |
| Independent Director | 4.5yrs | US$299.98k | 0.0016% $ 645.0k |
2.4yrs
Average Tenure
64yo
Average Age
Experienced Board: CNC's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.